-
Markeder
athexgroup.grAthens Exchange GroupLes merTogether for a unified, stronger European capital market.
-
Aksjer
Sustainable finance2025 Euronext ESG Trends ReportLes merA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indekser
Access the white paperInvesting in the future of Europe with innovative indicesLes merThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETF-er
The European market place for ETFsEuronext ETF EuropeLes merInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Fond
-
Obligasjoner
European Defence BondsGroupe BPCE lists the first bondLes merFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Strukturerte produkter
-
Derivater
Where European Government Bonds Meet the FutureFixed Income derivativesLes merTrade mini bond futures on main European government bonds
-
Råvarer
- Oversikt
- Agricultural quotes
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Container Freight Futures
- Levering og oppgjør
- Spesifikasjoner og ordninger
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesLes merEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Ressurser
Designed to help students navigate the complexities of financial marketsEuronext Trading gameLes merJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Company press releases
| Tid | Selskap | Tittel | Sektor | Kategori |
|---|---|---|---|---|
| 12 May 2023 22:00 CEST |
INNATE PHARMA | Résultats de l’Assemblée Générale mixte du 12 mai 2023 | 20103010 Biotechnology | General meeting / Board Meeting |
| 12 May 2023 22:00 CEST |
INNATE PHARMA | Outcome of Innate Pharma’s 2023 Annual General Meeting | 20103010 Biotechnology | General meeting / Board Meeting |
| 10 May 2023 07:00 CEST |
INNATE PHARMA | Innate Pharma Reports First Quarter 2023 Financial Results and Business Update | 20103010 Biotechnology | Products and services |
| 10 May 2023 07:00 CEST |
INNATE PHARMA | Innate Pharma : information financiere du premier trimestre 2023 | 20103010 Biotechnology | Products and services |
| 09 May 2023 07:00 CEST |
INNATE PHARMA | Nouveau nombre d’actions et de droits de vote d’Innate Pharma au 1er mai 2023 | 20103010 Biotechnology | Other subject |
| 09 May 2023 07:00 CEST |
INNATE PHARMA | Number of shares and voting rights of Innate Pharma as of May 1, 2023 | 20103010 Biotechnology | Other subject |
| 03 May 2023 07:17 CEST |
INNATE PHARMA | Innate Pharma annonce plusieurs abstracts cliniques acceptés au congrès annuel de l’ASCO 2023 | 20103010 Biotechnology | Products and services |
| 03 May 2023 07:00 CEST |
INNATE PHARMA | Innate Pharma Announces Conference Call and Webcast for Q1 Business Update | 20103010 Biotechnology | Meetings / events |
| 03 May 2023 07:00 CEST |
INNATE PHARMA | Innate Pharma organise une conférence téléphonique pour ses résultats au premier trimestre 2023 | 20103010 Biotechnology | Meetings / events |
| 03 May 2023 07:00 CEST |
INNATE PHARMA | Innate Pharma Highlights Clinical Abstracts Selected for ASCO 2023 Annual Meeting | 20103010 Biotechnology | Products and services |
| 26 Apr 2023 22:50 CEST |
INNATE PHARMA | Innate Pharma Establishes a New At-The-Market (“ATM”) Program on Nasdaq | 20103010 Biotechnology | Share introduction and issues |
| 26 Apr 2023 22:50 CEST |
INNATE PHARMA | Innate Pharma met en place un nouveau programme At-The-Market («ATM») sur le Nasdaq | 20103010 Biotechnology | Share introduction and issues |
| 21 Apr 2023 07:00 CEST |
INNATE PHARMA | Innate Pharma to Participate in Upcoming Investor Conference | 20103010 Biotechnology | Meetings / events |
| 21 Apr 2023 07:00 CEST |
INNATE PHARMA | Prochain rendez-vous investisseurs d'Innate Pharma | 20103010 Biotechnology | Meetings / events |